SYRS
Syros Pharmaceuticals Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
syros pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data--a proficiency that is not well represented in pharmaceutical r&d. central to the syros approach is a proprietary platform of carefully integrated assay technologies, bioinformatics, and biologic insights developed by members of syros' senior leadership. while this scientific approach has applications in many therapeutic areas, syros has demonstrated success initially in oncology, where it may help address numerous unmet medical needs.
Market Cap: 44.9 Million
Primary Exchange: NASDAQ
Website: https://syros.com/
Shares Outstanding: 6.3 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.41166788141291105
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 1215 trading days
From: 2017-08-07 To: 2024-03-07
Lowest Point:
Syros Announces Appointment of Alice T. Shaw to its Board of Directors
via: Business Wire at 2019-06-12 04:31:00:000
Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company pioneering the development of medicines to control the expression of genes, today announced the appointment of Alice Tsang Shaw, M.D., Ph.D., to the Companys Board of Directors. Dr. Shaw is a highly respected oncologis… read more...
Syros Announces Appointment of Alice T. Shaw to its Board of Directors
via: Business Wire at 2019-06-12 04:31:00:000
Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company pioneering the development of medicines to control the expression of genes, today announced the appointment of Alice Tsang Shaw, M.D., Ph.D., to the Companys Board of Directors. Dr. Shaw is a highly respected oncologis… read more...
Syros to Present at JMP Securities Life Sciences Conference
via: Business Wire at 2019-06-12 04:01:00:000
Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that its Chief Executive Officer, Nancy Simonian, M.D., will participate in a fireside chat at the JMP Securities Life Sciences Conference. Details are as follo… read more...
Syros to Present at JMP Securities Life Sciences Conference
via: Business Wire at 2019-06-12 04:01:00:000
Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that its Chief Executive Officer, Nancy Simonian, M.D., will participate in a fireside chat at the JMP Securities Life Sciences Conference. Details are as follo… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|